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Figure S1
Figure S1. Kinetics of TAT-RasGAP317-326-mediated adhesiveness increase.
A. U2OS cells were subjected to an adhesion assay for 30 minutes in presence of the indicated 
concentrations of TAT and TAT-RasGAP317-326 (the statistical significance of the observed 
differences was assessed by one-way ANOVA).
B. Representative images of the adhesion assay performed in Figure 1E. Scale bar: 100 µm.
C. Higher magnification of cells 30 minutes after plating. Scale bar: 40 µm.
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Figure S4
Figure S4. Integrins, CD44 and caspases are not required for TAT-RasGAP317-326-mediated adhesion increase.
A. The twenty-four known integrin heterodimers are represented (8).
B. Wild-type (M21) or αV-integrin-null (M21L) melanoma cells were treated 8 hours with 20 µM TAT, 20 µM TAT-RasGAP317-326 or left untreated. The cells 
were then subjected to a trypsin-mediated detachment assay.
C. HeLa cells were transfected with siRNAs targeted against GFP (siGFP) or β1-integrin (siIntegrin-β1). Forty-eight hours later, the cells were incubated 8 
hours with 20 µM TAT, 20 µM TAT-RasGAP317-326 or left untreated and were subjected to a trypsin-mediated detachment assay. The upper panel depicts the 
loss of β1-integrin expression after siRNA transfection.
D. Expression levels of the indicated integrin family members in U2OS cells [data taken from (9)].
E. CD44 was silenced in HeLa cells with siRNAs. Forty-eight hours later, the cells were incubated 8 hours with 20 µM TAT, 20 µM TAT-RasGAP317-326 or left 
untreated. The cells were then subjected to a trypsin-mediated detachment assay. The upper panel depicts the loss of CD44 expression after siRNA 
transfection.
F. U2OS cells were grown overnight on bacteriological Petri dishes that had been coated beforehand with collagen, fibronectin or laminin. The cells were 
then treated or not with 20 µM TAT or 20 µM TAT-RasGAP317-326 for 8 hours. A trypsin-based detachment assay was finally performed. Representative 
images of the cells remaining attached to the plates after trypsin treatment are shown. Scale bar: 100 µm.


